A detailed history of Public Employees Retirement System Of Ohio transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 48,990 shares of NBIX stock, worth $6.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
48,990
Previous 47,947 2.18%
Holding current value
$6.15 Million
Previous $6.61 Million 2.0%
% of portfolio
0.03%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $136,486 - $149,347
1,043 Added 2.18%
48,990 $6.74 Million
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $389,504 - $429,351
2,987 Added 6.64%
47,947 $6.61 Million
Q4 2023

Feb 15, 2024

BUY
$106.07 - $132.76 $577,975 - $723,409
5,449 Added 13.79%
44,960 $5.92 Million
Q3 2023

Dec 19, 2023

SELL
$94.02 - $117.1 $406,072 - $505,754
-4,319 Reduced 9.85%
39,511 $4.44 Million
Q3 2023

Nov 15, 2023

SELL
$94.02 - $117.1 $406,072 - $505,754
-4,319 Reduced 9.85%
39,511 $4.45 Million
Q2 2023

Dec 19, 2023

SELL
$89.53 - $104.87 $343,437 - $402,281
-3,836 Reduced 8.05%
43,830 $4.13 Million
Q2 2023

Aug 15, 2023

SELL
$89.53 - $104.87 $343,437 - $402,281
-3,836 Reduced 8.05%
43,830 $4.13 Million
Q1 2023

Dec 19, 2023

SELL
$94.11 - $123.02 $86,392 - $112,932
-918 Reduced 1.89%
47,666 $4.82 Million
Q1 2023

May 15, 2023

SELL
$94.11 - $123.02 $86,392 - $112,932
-918 Reduced 1.89%
47,666 $4.83 Million
Q4 2022

Dec 19, 2023

BUY
$106.72 - $127.06 $968,270 - $1.15 Million
9,073 Added 22.96%
48,584 $5.8 Million
Q4 2022

Feb 15, 2023

BUY
$106.72 - $127.06 $108,854 - $129,601
1,020 Added 2.14%
48,584 $5.8 Million
Q3 2022

Nov 15, 2022

BUY
$92.03 - $107.81 $34,419 - $40,320
374 Added 0.79%
47,564 $5.05 Million
Q2 2022

Aug 15, 2022

SELL
$75.79 - $100.07 $107,621 - $142,099
-1,420 Reduced 2.92%
47,190 $4.6 Million
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $121,716 - $159,280
-1,680 Reduced 3.34%
48,610 $4.56 Million
Q4 2021

Feb 15, 2022

SELL
$79.65 - $106.22 $153,405 - $204,579
-1,926 Reduced 3.69%
50,290 $4.28 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $101,261 - $116,360
-1,175 Reduced 2.2%
52,216 $5.01 Million
Q2 2021

Aug 16, 2021

BUY
$89.43 - $102.27 $354,500 - $405,398
3,964 Added 8.02%
53,391 $5.2 Million
Q1 2021

May 14, 2021

BUY
$87.57 - $119.4 $369,808 - $504,226
4,223 Added 9.34%
49,427 $4.81 Million
Q4 2020

Feb 12, 2021

BUY
$86.91 - $108.33 $758,811 - $945,829
8,731 Added 23.94%
45,204 $4.33 Million
Q3 2020

Nov 16, 2020

BUY
$96.16 - $135.15 $133,470 - $187,588
1,388 Added 3.96%
36,473 $3.51 Million
Q2 2020

Aug 17, 2020

SELL
$85.09 - $130.36 $31,313 - $47,972
-368 Reduced 1.04%
35,085 $4.28 Million
Q1 2020

May 13, 2020

BUY
$75.11 - $113.76 $347,008 - $525,571
4,620 Added 14.98%
35,453 $3.07 Million
Q4 2019

Feb 14, 2020

SELL
$86.8 - $118.57 $1.64 Million - $2.24 Million
-18,866 Reduced 37.96%
30,833 $3.31 Million
Q3 2019

Nov 15, 2019

BUY
$83.82 - $101.5 $2,263 - $2,740
27 Added 0.05%
49,699 $4.48 Million
Q2 2019

Aug 12, 2019

SELL
$72.24 - $91.27 $86,326 - $109,067
-1,195 Reduced 2.35%
49,672 $4.19 Million
Q1 2019

May 15, 2019

BUY
$69.31 - $91.53 $291,587 - $385,066
4,207 Added 9.02%
50,867 $4.48 Million
Q4 2018

Feb 15, 2019

SELL
$68.32 - $124.36 $230,648 - $419,839
-3,376 Reduced 6.75%
46,660 $3.33 Million
Q3 2018

Nov 14, 2018

SELL
$98.88 - $125.85 $138,728 - $176,567
-1,403 Reduced 2.73%
50,036 $6.15 Million
Q2 2018

Aug 22, 2018

SELL
$75.3 - $105.99 $17,620 - $24,801
-234 Reduced 0.45%
51,439 $5.05 Million
Q1 2018

May 15, 2018

BUY
$75.88 - $92.43 $1.08 Million - $1.32 Million
14,244 Added 38.06%
51,673 $4.29 Million
Q4 2017

Feb 08, 2018

BUY
$58.53 - $77.59 $110,094 - $145,946
1,881 Added 5.29%
37,429 $2.9 Million
Q3 2017

Nov 20, 2017

SELL
$47.97 - $61.28 $56,892 - $72,678
-1,186 Reduced 3.23%
35,548 $2.18 Million
Q2 2017

Aug 16, 2017

BUY
N/A
36,734
36,734 $1.69 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.